References
- WHO Director-General’s opening remarks at the media briefing on COVID-19 [Internet]. 2020 [cited 2020 Oct 10]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020
- Mortaz E, Tabarsi P, Varahram M, et al. The immune response and immunopathology of COVID-19. Front Immunol. 2020;11:2037.
- Dobesh PP, Trujillo TC. Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID-19. Pharmacotherapy. 2020;40(11):1130–1151.
- Szegedi I, Orbán-Kálmándi R, Csiba L, et al. Stroke as a potential complication of COVID-19-associated coagulopathy: a narrative and systematic review of the literature. J Clin Med. 2020;9(10):3137.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
- Borobia AM, Carcas AJ, Arnalich F, et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med. 2020;9(6):1733.
- Iacob S, Iacob DG. SARS-CoV-2 treatment approaches: numerous options, no certainty for a versatile virus. Front Pharmacol. 2020;11:1224.
- Sisó-Almirall A, Kostov B, Mas-Heredia M, et al. Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS One. 2020;15(8):e0237960.
- Shi S, Liu X, Xiao J, et al. Prediction of adverse clinical outcomes in patients with coronavirus disease 2019. J Clin Lab Anal. 2021;35(1):e23598. Epub ahead of print. PMID: 32989838.
- Cheng B, Hu J, Zuo X, et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Microbiol Infect. 2020;26(10):1400–1405.
- Ji D, Zhang D, Xu J, et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis. 2020;71(6):1393–1399.
- Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442–453.
- Galloway JB, Norton S, Barker RD, et al. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study. J Infect. 2020;81(2):282–288.
- Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089.
- Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.
- Altschul DJ, Unda SR, Benton J, et al. A novel severity score to predict inpatient mortality in COVID-19 patients. Sci Rep. 2020;10(1):16726. PMID: 33028914.
- Torres-Macho J, Ryan P, Valencia J, et al. The PANDEMYC score. An easily applicable and interpretable model for predicting mortality associated with COVID-19. J Clin Med. 2020;9(10):3066. PMID: 32977606.
- Pranata R, Lim MA, Yonas E, et al. Body mass index and outcome in patients with COVID-19: a dose–response meta-analysis. Diabetes Metab. 2020;S1262-3636(20)30097-5.
- Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. ENE-COVID study group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535–544.